In developed and developing countries, 7-10% of hospitalized patients will acquire an HAI.1
Rapid diagnostic techniques, like the cobas® MRSA/SA Test, enable the early detection of methicillin-resistant Staphylococcus aureus (MRSA) in colonized patients, supporting the timely implementation of appropriate barrier precautions.
Reliable surveillance programs that quickly and accurately detect colonized patients can help reduce the worldwide burden and spread of these costly, and potentially deadly infections.
Roche offers a broad portfolio of assays and systems to support the detection of hospital-acquired infections.
- World Health Organization (WHO). Health care-associated infections Fact Sheet. http://www.who.int/gpsc/country_work/gpsc_ccisc_fact_sheet_en.pdf. Accessed May 11, 2016.